These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21152992)

  • 1. Effects of yokukansan on anxiety-like behavior in a rat model of cerebrovascular dementia.
    Nogami A; Sakata Y; Uchida N; Yamaguchi K; Kawasaki C; Shindo T; Kubota K; Katsurabayashi S; Takasaki K; Mishima K; Nishimura R; Fujiwara M; Iwasaki K
    J Nat Med; 2011 Apr; 65(2):275-81. PubMed ID: 21152992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
    J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain region-specific reduction in c-Fos expression associated with an anxiolytic effect of yokukansan in rats.
    Shoji H; Mizoguchi K
    J Ethnopharmacol; 2013 Aug; 149(1):93-102. PubMed ID: 23770052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yokukansan, a traditional Japanese herbal medicine, enhances the anxiolytic effect of fluvoxamine and reduces cortical 5-HT
    Ohno R; Miyagishi H; Tsuji M; Saito A; Miyagawa K; Kurokawa K; Takeda H
    J Ethnopharmacol; 2018 Apr; 216():89-96. PubMed ID: 29382554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extract of Yokukansan improves anxiety-like behavior and increases serum brain-derived neurotrophic factor in rats with cerebral ischemia combined with amyloid-42 peptide.
    Ai NH; Kaori K; Kotaro T; Takuya W; Hikari I; Risako F; Shutaro K; Katsunori I; Kaori K; Takuya W; Katsunori I; Nobuaki E; Funda BH; Izzettin HA
    J Tradit Chin Med; 2019 Feb; 39(1):50-58. PubMed ID: 32186023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Japanese Angelica acutiloba root and yokukansan increase hippocampal acetylcholine level, prevent apoptosis and improve memory in a rat model of repeated cerebral ischemia.
    Nogami-Hara A; Nagao M; Takasaki K; Egashira N; Fujikawa R; Kubota K; Watanabe T; Katsurabayashi S; Hatip FB; Hatip-Al-Khatib I; Iwasaki K
    J Ethnopharmacol; 2018 Mar; 214():190-196. PubMed ID: 29269276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats.
    Kanno H; Sekiguchi K; Yamaguchi T; Terawaki K; Yuzurihara M; Kase Y; Ikarashi Y
    J Pharm Pharmacol; 2009 Sep; 61(9):1249-56. PubMed ID: 19703376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yokukansan, a traditional Japanese medicine, decreases head-twitch behaviors and serotonin 2A receptors in the prefrontal cortex of isolation-stressed mice.
    Ueki T; Mizoguchi K; Yamaguchi T; Nishi A; Sekiguchi K; Ikarashi Y; Kase Y
    J Ethnopharmacol; 2015 May; 166():23-30. PubMed ID: 25732836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats.
    Ikarashi Y; Iizuka S; Imamura S; Yamaguchi T; Sekiguchi K; Kanno H; Kawakami Z; Yuzurihara M; Kase Y; Takeda S
    Biol Pharm Bull; 2009 Oct; 32(10):1701-9. PubMed ID: 19801831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.
    Matsunaga S; Kishi T; Iwata N
    J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ameliorative effects of yokukansan on behavioral deficits in a gerbil model of global cerebral ischemia.
    Liu Y; Nakamura T; Toyoshima T; Lu F; Sumitani K; Shinomiya A; Keep RF; Yamamoto T; Tamiya T; Itano T
    Brain Res; 2014 Jan; 1543():300-7. PubMed ID: 24269335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex.
    Egashira N; Iwasaki K; Ishibashi A; Hayakawa K; Okuno R; Abe M; Uchida N; Mishima K; Takasaki K; Nishimura R; Oishi R; Fujiwara M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1516-20. PubMed ID: 18558456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic effect of a herbal medicine, yokukansan, in aged rats: involvement of serotonergic and dopaminergic transmissions in the prefrontal cortex.
    Mizoguchi K; Tanaka Y; Tabira T
    J Ethnopharmacol; 2010 Jan; 127(1):70-6. PubMed ID: 19799980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
    Teranishi M; Kurita M; Nishino S; Takeyoshi K; Numata Y; Sato T; Tateno A; Okubo Y
    J Clin Psychopharmacol; 2013 Oct; 33(5):600-7. PubMed ID: 23948783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADN-1184, a monoaminergic ligand with 5-HT6/7 receptor antagonist action, exhibits activity in animal models of anxiety.
    Partyka A; Wasik A; Jastrzębska-Więsek M; Mierzejewski P; Bieńkowski P; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):593-602. PubMed ID: 26979176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of Yokukansan on social isolation-induced aggressive behavior of zinc-deficient and pair-fed mice.
    Takeda A; Iwaki H; Ide K; Tamano H; Oku N
    Brain Res Bull; 2012 Apr; 87(6):551-5. PubMed ID: 22373913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA and 5-HT systems are implicated in the anxiolytic-like effect of spinosin in mice.
    Liu J; Zhai WM; Yang YX; Shi JL; Liu QT; Liu GL; Fang N; Li J; Guo JY
    Pharmacol Biochem Behav; 2015 Jan; 128():41-9. PubMed ID: 25449359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yokukansan for perioperative psychiatric symptoms in cancer patients undergoing high invasive surgery. J-SUPPORT 1605 (ProD Study): study protocol for a randomized controlled trial.
    Wada S; Sadahiro R; Matsuoka YJ; Uchitomi Y; Yamaguchi T; Shimizu K
    Trials; 2019 Feb; 20(1):110. PubMed ID: 30736826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines.
    Sugiyama A; Saitoh A; Iwai T; Takahashi K; Yamada M; Sasaki-Hamada S; Oka J; Inagaki M; Yamada M
    Neuropharmacology; 2012 Jun; 62(8):2489-98. PubMed ID: 22377384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementia.
    Kung FC; Ishii R; Liu HC; Takeda M
    Clin Interv Aging; 2012; 7():393-6. PubMed ID: 23055705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.